OR WAIT null SECS
© 2021 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
December 07, 2021
Roadmap of twists and turns that lie ahead following most recent draft issued in September.
Lessons learned from FDA’s current process and proposed alternative review strategies.
Increased public engagement leads recent change in EMA profile.
Lessons learned from COVID-19 vaccine development.
November 15, 2021
Improving receptivity and response to the evolving nature of clinical trial patient oversight.
November 04, 2021
Implementing new strategies with the use of patient-reported outcomes.
October 14, 2021
Higher costs headline list of new challenges faced by CROs and sponsors.
August 31, 2021
The data, not the plan, provide the direction.
April 30, 2021
Developing new pathways to overcome study-related challenges is key to realizing the promise of the latest gene therapies.
February 12, 2021
FDA emphasizes importance of inclusion in trials.